Residual brain injury after early discontinuation of cooling therapy in mild neonatal encephalopathy.
Peter J LallyPaolo MontaldoVânia OliveiraRavi Shankar SwamyAung SoeSeetha ShankaranSudhin ThayyilPublished in: Archives of disease in childhood. Fetal and neonatal edition (2017)
We examined the brain injury and neurodevelopmental outcomes in a prospective cohort of 10 babies with mild encephalopathy who had early cessation of cooling therapy. All babies had MRI and spectroscopy within 2 weeks after birth and neurodevelopmental assessment at 2 years. Cooling was prematurely discontinued at a median age of 9 hours (IQR 5-13) due to rapid clinical improvement. Five (50%) had injury on MRI or spectroscopy, and two (20%) had an abnormal neurodevelopmental outcome at 2 years. Premature cessation of cooling therapy in babies with mild neonatal encephalopathy does not exclude residual brain injury and adverse long-term neurodevelopmental outcomes. This study refers to babies recruited into the MARBLE study (NCT01309711, pre-results stage).
Keyphrases
- brain injury
- subarachnoid hemorrhage
- gestational age
- cerebral ischemia
- early onset
- magnetic resonance imaging
- contrast enhanced
- stem cells
- type diabetes
- computed tomography
- congenital heart disease
- magnetic resonance
- insulin resistance
- bone marrow
- diffusion weighted imaging
- blood brain barrier
- mass spectrometry
- quantum dots
- adverse drug